Scinai Immunotherapeutics Ltd. American Depositary Shares
$1.54
-$0.90 (-36.89%)
$1.50Day Range$1.88
Key Statistics
Market Cap
$1.04M
Shares Outstanding
0.7M
Primary Exchange
XNAS
Currency
USD
Type
ADRC
IPO Date
May 12, 2015
Round Lot
100
Locale
US
Trading Data
Day Open
$1.84
Day High
$1.88
Day Low
$1.50
Volume
1.43M
VWAP
$1.70
Prev Close
$2.44
Transactions
--
Acc. Volume
--
About Scinai Immunotherapeutics Ltd. American Depositary Shares
Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units: (i) Scinai R&D, focused on the development of therapeutics in inflammation and immunology, and (ii) the contract development and manufacturing organization (CDMO) business. The CDMO business provides integrated development and manufacturing services to small and emerging biotech companies, supporting clients from early-stage development through clinical-stage production.
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)SIC 283645 employeesJERUSALEM BIOPARK, 2ND FLOOR, JERUSALEM, L3, 00000972-8-9302529IPO May 12, 2015US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001611747
- Composite FIGI
- BBG007TGL1R2
- Share Class FIGI
- BBG007TGL3Q9
- Ticker Root
- SCNI
- SIC Code
- 2836
About Scinai Immunotherapeutics Ltd. American Depositary Shares (SCNI) Stock
Scinai Immunotherapeutics Ltd. American Depositary Shares (SCNI) closed the 2026-09-15 session at $1.54, down 36.89% versus the previous close (-0.90). The stock opened at $1.84 and traded between $1.50 and $1.88 during that session. Session trading volume was 1.4M shares. The volume-weighted average price (VWAP) is $1.70.
Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units: (i) Scinai R&D, focused on the development of therapeutics in inflammation and immunology, and (ii) the contract development and manufacturing organization (CDMO) business. The CDMO business provides integrated development and manufacturing services to small and emerging biotech companies, supporting clients from early-stage development through clinical-stage production.
Scinai Immunotherapeutics Ltd. American Depositary Shares has a market capitalization of $1.0 million. The company operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) industry classification. SCNI is listed on the XNAS exchange. The company employs approximately 45 people. Scinai Immunotherapeutics Ltd. American Depositary Shares is headquartered in JERUSALEM, L3. The recorded listing date is 2015-05-12.
On this page you can find market SCNI stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.